StartupsAnnuaire
Solutions sectoriellesUtilise l’IA
Brainstorm Cell Therapeutics
BrainStorm Cell Therapeutics (OTCQB: BCLI) develops NurOwn®, an autologous MSC-NTF cell therapy for ALS, under an FDA-agreed Special Protocol Assessment.
En bref
- Région
- Israel
- Référencé
- Sources
Lieu
LOADING MAP…